Trending Now
Novo Integrated Sciences Inc (NASDAQ: NVOS) Announces Board Changes and Receives...
Novo Integrated Sciences Inc (NASDAQ: NVOS), a prominent player in the healthcare and medical sciences sector, recently made two significant announcements that...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
OncoCyte Corp (NYSEAMERICAN:OCX) Provides Update On DetermaRx’s Global Growth And Adoption
OncoCyte Corp (NYSEAMERICAN:OCX) provided a growth and adoption update on its non-small cell lung cancer (NSCLC) treatment stratification test called DetermaRx towards the end...
MAKE IT MODERN
LATEST REVIEWS
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Posts Revenues Of $62.4 Million In Q2...
Amicus Therapeutics, Inc. (NASDAQ:FOLD) reported a growth of 41% YoY to $62.4 million in Q2 2020. It is on the backdrop of strong patient...
MAKE IT MODERN
PERFORMANCE TRAINING
Health & Wellness Stocks with Potential for Major Outperformance (USNA, GTEH, HLF, BRBR, CELH,...
The Health and Wellness market space has evolved from a self-improvement ideal to a lifestyle, and it appears to be a strong...
China Trade Deal Optimism sends Wall Street into a tizzy
Markets are a bit all over the place today. The SPY is up almost 0.4%, while the IWM is down 0.66%, the...
TFF Pharmaceuticals Inc. (NASDAQ:TFFP) Reports the Development of the First dosing of Tacrolimus Inhalation...
TFF Pharmaceuticals Inc. (NASDAQ:TFFP) has taken on the second clinical trial program of dosing healthy subjects with Tacrolimus Inhalation Powder. The study will assess...
Singular Genomics (OMIC) Surges Over 65% Following recent Acquisition Proposal from Concentra Biosciences: What...
Singular Genomics Systems, Inc. (Nasdaq: OMIC), an innovative player in next-generation sequencing (NGS) and spatial multiomics technology, saw its stock skyrocket by...
Catalyst Biosciences Inc. (NASDAQ: CBIO) Receives Rare Paediatric Diseases Designation for CB 4332 in...
Catalyst Biosciences Inc. (NASDAQ: CBIO) has announced that the FDA has granted CB 4332 a Rare Paediatric Disease Designation (RPDD) for Complement Factor 1...
MAKE IT MODERN
